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Abstract
Background: Internationally, women with cervical intraepithelial neoplasia (CIN) lack knowledge about their disease,
which limits their ability to take responsibility for self-care and creates negative psychosocial effects, including marital
problems. Normally, screening is performed in primary care, and in case of abnormal results, the patient is referred to
specialized care for follow-up and treatment. Given the lack of international literature regarding patients’ experiences in
primary and specialized healthcare, our study aims to: (a) investigate how women with CIN perceive the
communication and management of information by healthcare providers at different moments of their healthcare and
(b) identify these women’s informational needs.
Methods: A qualitative exploratory study was carried out in a gynecology unit of a public hospital of the Galician
Health Care Service (Spain). Participants were selected through purposive sampling. The sample consisted of 21
women aged 21 to 52 years old with a confirmed diagnosis of CIN. Semistructured interviews were recorded and
transcribed. A thematic analysis was carried out, including triangulation of researchers for analysis verification.
Results: Two analytical themes were identified. The first was communication gaps in the diagnosis and management
of information in primary and specialized healthcare. These gaps occurred in the following moments of the healthcare
process: (a) cervical cancer screening in primary care, (b) waiting time until referral to specialized care, (c) first
consultation in specialized care, and (d) after consultation in specialized care. The second theme was participants’
unmatched informational needs. The doubts and informational needs of women during their healthcare process
related to the following subthemes: (a) HPV transmission, (b) HPV infection symptoms and consequences, and (c) CIN
treatment and follow-up.
Conclusions: This study shows that women who have a diagnosis of CIN experience important healthcare
informational challenges when accessing primary and specialized care that have several implications for their
wellbeing. The information given is limited, which makes it difficult for women to understand and participate in the
decision making regarding the prevention and treatment of CIN. Service coordination among different levels of care
and the availability of educational materials at any given time would improve the patients’ healthcare experience.
Keywords: Cervical intraepithelial neoplasia, Papillomavirus infections, Health education, Patient care, Patient
satisfaction, Patient rights
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Background
Human papillomavirus (HPV) infection is one of the
most common sexually transmitted infections worldwide
[1] and is the cause of all cervical cancer cases [2]. Pres-
ently, the prevention of cervical cancer is based on vac-
cination against HPV infection and screening for the
early detection of precancerous cervical lesions, known
as cervical intraepithelial neoplasia (CIN) [1].
Internationally, researchers have shown that health
care informational challenges for women diagnosed
with CIN limit their ability to self-care [3, 4] and lead
to several negative psychological effects [5, 6].
Women with CIN lack knowledge about their condi-
tion [3, 5, 7, 8] and experience anxiety [3, 9], fear of
cancer [3, 10, 11], guilt, shame and feelings of
stigmatization [12], and they also have problems in
their social [13, 14] and intimate relationships [11,
14]. Researchers have also shown that there is no ad-
equate flow of information between health care pro-
viders and patients [7, 9, 11] and that health care
providers have knowledge gaps about infection, test-
ing and HPV vaccination [15]. However, in Spain,
there are no studies on the users’ experience in this
context. Previous Spanish studies have focused on
cervical cancer screening evaluation [16], the preva-
lence of precancerous lesions and the types of HPV
present in cytological samples [17–19] as well as HPV
vaccination [20–24].
Similar to that in many other countries, the Spanish
National Health Care System [25] establishes that cyto-
logical screening should be performed in primary care,
and in case of abnormal results, the patient should be re-
ferred to specialized care for follow-up and treatment.
Given the lack of international and Spanish literature re-
garding patients’ experiences in primary and specialized
health care, we have designed a study to (a) investigate
how women with CIN perceive the communication and
management of information by health care providers at
different moments of their health care and (b) identify
these women’s informational needs.
Methods
A qualitative exploratory study was carried out in a
gynecology unit in a public hospital of the Galician
Health Care Service (Spain). A researcher (CFV) ac-
companied the gynecological team during the consul-
tations and personally made the study known to the
participants. Those who agreed to participate in the
study were scheduled to meet at another time in a
consultation room reserved for this research. In this
meeting, participants were explained the objectives of
the study and what their participation entailed. They
were also given an information sheet, and the
informed consent was read, clarified and signed be-
fore the interview.
Participants were selected through purposive sampling
[26] fulfilling the following inclusion criteria: women be-
tween 21 and 65 years old, with diagnostic confirmation
of CIN of any degree and able to communicate in Span-
ish. Women with a diagnosis of cervical cancer and
physical and/or mental comorbidity that interfered with
the description of the phenomenon were excluded from
the study. Initially, 31 women agreed to participate, 5 of
whom decided not to participate for personal reasons
and another 5 of whom did not attend the interview
without prior notice or justification. This resulted in a
final sample of 21 participants: 15 were in preventive fol-
low-up, and 6 were in follow-up after conization. The
sociodemographic characteristics of the sample are de-
scribed in Table 1.
The first author (CFV) conducted all semistructured
interviews. The interview guide was based on the litera-
ture review and on the advice of three expert reviewers,
two in qualitative methodology (MJMF, CC) and one in
HPV infection (Table 2). The interviews were conducted
from October to December 2015, with the majority of
interviews lasting approximately 40 min. They were
audio recorded and transcribed; after the verification of
the accuracy of the transcription, recordings were
destroyed. Field notes were integrated into the tran-
scripts to enrich data.
The study obtained the approval of the Autonomic
Committee of Research Ethics of Galicia (Spain) with
registration code 2015/230 and had the permission of ac-
cess to the field by hospital management. The interviewer
(CFV), a nurse, did not belong to the gynecological service
where the study took place. This allowed women to talk
freely about their perceptions, without feeling that their
participation would interfere with their health care. The
interviewees had many doubts about the HPV diagnostic.
The researcher addressed their informational needs at the
end of each interview.
A thematic analysis was carried out [27], including
identification of units of meaning and codes that were
grouped into subcategories and analytical categories.
Saturation was reached for the two themes presented
in this article. Throughout this inductive process, ana-
lytical memos were developed to guide the analysis
and ATLAS.ti was used for data management (version
7.5.10).
To ensure trustworthiness [28], triangulation of
sources was carried out among three researchers (CFV,
MJMF and DG) who read and analyzed the transcripts.
The final categories were agreed upon by the entire
team. The verification of information was carried out
during the interviews, since it was not possible to meet
participants again.
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Results
Two analytical themes were identified. The first theme
was communication gaps in the diagnosis and manage-
ment of information in primary and specialized health
care. These gaps occurred in the following moments of
the health care process: (a) cervical cancer screening in
primary care, (b) waiting time until referral to special-
ized care, (c) first consultation in specialized care, and
(d) after consultation in specialized care. The second
theme was participants’ unmatched informational needs.
The doubts and informational needs of women during
their health care process related to the following sub-
themes: (a) HPV transmission, (b) HPV infection
symptoms and consequences, and (c) CIN treatment and
follow-up.
Communication gaps in the diagnosis and management
of information in primary and specialized health care
Figure 1 presents a summary of the experiences of
women with CIN in relation to health care providers’
communication and management of information during
the health care process at two levels of care: primary and
specialized. Four key moments were identified: cervical
cancer screening in primary care, waiting time until re-
ferral to specialized care, first consultation in specialized
care and after consultation in specialized care.
Cervical cancer screening in primary care
Several participants of this study expressed that they had
pap smears performed without knowing their purpose.
This led to perplexity when participants received an un-
expected result of abnormal findings, and especially
when the information was communicated by telephone.
“You take this test to see if everything is all right, but
what exactly? In the end, you don’t know what’s going
on. You know that this test should be done, but what
is it all about? What are they looking for? You don’t
know.” I-11
Table 2 Semistructured interview script
Experience of being told the diagnosis by a health care professional.
Management of information related to the diagnosis: HPV transmission,
treatment, changes in lifestyle, etc.
Experience of the process of receiving and searching for information.
Information sources.
Description of advice given by health professionals.
Considerations to improve the information process based on their
lives and experiences.
Table 1 Sociodemographic characteristics
Participant Age Academic level Marital status No. Children Type of diagnostic Year of diagnostic
I-1 33 Graduate degree Single (with partner) 0 CIN 1 2013
I-2 23 Compulsory secondary education Single (with partner) 0 CIN 2 2015
I-3 29 Higher vocational training Single (without partner) 0 CIN 1 2008
I-4 46 Graduate degree Married 2 CIN 1 2015
I-5 25 Graduate degree Single (with partner) 0 CIN 3 2015
I-6 33 Baccalaureate degree Single (with partner) 0 CIN 3 2013
I-7 21 Associate degree Single (with partner) 0 CIN 1 2012
I-8 26 Graduate degree Single (with partner) 0 CIN 1 2014
I-9 45 Compulsory secondary education Married 2 CIN 1 2014
I-10 42 Graduate degree Married 1 CIN 3 2010
I-11 39 Higher vocational training Separated (with partner) 1 CIN 2 2012
I-12 27 Graduate degree Single (with partner) 0 CIN 2 2014
I-13 35 Higher vocational training Married 1 CIN 1 2015
I-14 52 Graduate degree Married 1 CIN 1 2010
I-15 25 Higher vocational training Single (without partner) 0 CIN 1 2012
I-16 37 Associate degree Single (with partner) 0 CIN 1 2007
I-17 29 Graduate degree Married 0 CIN 1 2013
I-18 26 Graduate degree Married 0 CIN 1 2010
I-19 48 Associate degree Divorced (with partner) 1 CIN 1 2015
I-20 44 Baccalaureate degree Married 2 CIN 3 2005
I-21 34 Higher vocational training Single (with partner) 0 CIN 1 2014
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“I was working when I got a phone call. I was told ‘the
test showed some… atypical… cells’. It scared me to
death. I burst out crying… I had no idea what it all
meant.” I-13
Waiting time until referral to specialized care
According to the participants’ accounts, some health
care providers did not give information about the diag-
nosis, and limited themselves to referring women to a
gynecological service. This became a situation of great
uncertainty (which varied depending on the CIN sever-
ity) as the participants had to wait until an appointment
to learn more about the diagnosis.
“You are only told that you have a problem but
without an explanation. You are absolutely confused.
You ask for a gynecological appointment, but there’s a
waiting period which only adds more anxiety. When
you are told you have a problem, you want to know
exactly what’s going on right away.” I-4
First consultation in specialized care
Most women agreed that the first information they re-
ceived came from gynecologists in specialized health
care during the first consultation.
“I came to the hospital for the first time, and it was
there when the gynecologist asked me openly: ‘Tell me
what doubts you have’. But, the thing is that I didn’t
even have any doubts because I was completely
ignorant about the subject… I only knew what the
family physician had told me which was that I
couldn’t ignore these results and that I had to be
checked again…” I-18
Under specialized health care, participants received in-
formation at the time of the scheduled consultations
(every 6months or once a year), and it was difficult or
impossible for them to request an additional
gynecological appointment to resolve their doubts.
“You get some raw information, and later, when days
go by, you start coming up with questions. Obviously,
you cannot come [to specialized health care] every day
to ask questions. They do try to explain things. I was
given some good explanations [in specialized health
care].… The thing is that afterwards you can’t stop
thinking about all these things… but… you know, it’s
not like you can come to ask questions every day.” I-11
After consultation in specialized care
In search of additional information, our participants
turned to the Internet but could not find answers to
many of their questions, which generated more worries.
“You are driven by fear, and it makes you look things
up on the Internet, which is obviously not the best
Fig. 1 Experiences of women with CIN in relation to health care providers’ communication and management of information during the health
care process at two levels of care: primary and specialized
Freijomil-Vázquez et al. BMC Women's Health          (2019) 19:112 Page 4 of 10
place. I learned this the hard way because it only
made me feel more scared.” I-1
Women pointed out that the solution could be that pri-
mary care providers are made responsible for informa-
tion during their routine consultations. They identified
primary care as the preferred level of care to obtain in-
formation on a continual basis due to the greater acces-
sibility to health care professionals and availability of
appointments.
“Doubts keep coming up as time passes, but you feel
you have nobody to speak to. You can’t call your
gynecologist directly. However, you can go to your
family physician. For example, there are phone
consultations available, as well as face to face. You
can ask questions this way.” I-21
“I think [the information given by professionals] is
highly technical. I remember feeling much more
relaxed after speaking to my family physician. Family
physicians make an effort to explain it in basic terms
so that you can understand it better.” I-6
In summary, participants identified that their lack of
previous information, the time when information was of-
fered, the technical language used by specialists, and the
lack of opportunity to ask questions outside the annual
or semiannual appointment were circumstances that
were interrelated and interfered with their understand-
ing of CIN and its medical follow-up process.
Participants’ unmatched informational needs
The relationship between CIN and cancer added tension
and uncertainty to the follow-up process as illustrated
by the following account of a participant: “It might be
cancer... All those things they don’t tell you, they don’t ex-
plain these things to you clearly” (I-7). The participants’
unmatched informational needs included doubts about
all key aspects of CIN and HPV infection, including
transmission, symptoms, treatment and follow-up, as de-
scribed below.
HPV transmission
The majority of the women said they knew that HPV is
a sexually transmitted virus, although some questioned
whether it could be “produced” by the woman/man’s
own body.
“Some people say that women produce the virus. Others
tell you that’s not the case, that it comes from men that
either produce it or pass it on. While others assure you
that women can develop it either by producing it or
getting it, like a yeast infection. I don’t know.” I-11
Participants did not know how the infection was
transmitted through distinct sexual practices, and
wondered especially about possible transmission
through oral sex.
“I don’t know if you can get this simply by touching
hands or something like that. Is it only transmitted
through penetration or ejaculation…? You try to
follow all necessary precautions, but you are not
given more information.” I-3
“I have also read things…that the virus doesn’t only
affect the cervix. Reportedly, Catherine Z. Jones’
husband had throat cancer caused by this. I don’t
know whether it’s true or not. When you go to see the
gynecologist, they only tell you about what you have
down there [in the cervix]. They don’t tell you to be
careful—that this or that can happen if you do certain
sexual practices.” I-15
Participants also wondered whether having acquired the
infection could be due to infidelity on the part of their
current partner, unaware of the fact that the virus has a
long latency period.
“I knew who I had been with. You have to ask the
other person, though. You corner him and ask: ‘Who
have you been with? Where?’ If I got CIN 1 in 2014,
and in 2013 I got a negative result. You wonder…
something must have happened in between.
Supposedly, the pap smear was done right in the past.
So, there wasn’t any doubts about the previous year.
My reasoning was: if my conscience is clear, and you
know that it wasn’t your doing, you automatically
blame the other person.” I-9
“I had sex with two men…and that was it. I don’t
really know if it is something that they pass on to you
or if it develops in time…. I honestly don’t know.” I-18
Some participants also considered other possibilities for
transmission; they wondered if HPV could be acquired
in public restrooms, sharing objects or by having previ-
ously been vaccinated against it.
“You use your sponge in the shower, your partner has
another one. But who knows? They are touching one
another. If this is the case, it is obvious you are going to
be exposed sooner or later. I don’t know if it is so easy for
it to spread, only by touching infected objects.” I-21
“Or apart from sexual transmission, what about
public restrooms? Could it be transmitted this
way?” I-18
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“I didn’t meet any of the risk factors: I wasn’t a
smoker, I wasn’t taking any oral contraceptives, I
hadn’t been with different partners so, I thought: ‘Why
me? Was it the vaccine?’ I stopped asking the
gynecologist, but surely I did used to ask this question
every time I went to a consultation. According to them,
there are many different virus strains, and I’m
supposed to trust them. But, the truth is that I didn’t
have anything, and then, suddenly, I got a positive
result after getting the vaccine.” I-10
HPV infection symptoms and consequences
When the participants were diagnosed with CIN, they
asked themselves what it was they had, potential symptoms
(as they did not feel anything unusual), where the lesions
were located, and if it could affect other areas of the body.
“What did I have down there? What was that? I don’t
know. Maybe a little wart, a small injury.… What
exactly? Abnormal cells of what?” I-17
“I can’t tell you where my lesions are exactly. You are
not told that information. Only that you have CIN 1,
and that’s it.” I-16
“I really don’t know if the fact that my vagina gets
swollen more on the inside than on the outside, if that
has anything to do with the virus. I don’t think so.
Sometimes I say to myself: Damn it. It is really swollen
on the inside, it hurts, or whatever.” I-18
“Also, what other areas can be affected? Other than
your cervix, … maybe it can spread to other parts of
the body or whatever.” I-15
Participants also lacked knowledge about the evolu-
tion of their precancerous lesions to cancer and the
influence of the infection on fertility and pregnancy
(contagion to the fetus, abortion or increased possibil-
ity of developing cancer), which also created reasons
for concern.
“So, I was like…. How fast can this develop? I went
home thinking that I was bound to have cancer
sooner or later.” I-18
“But, if it is not healed, can you have children? I’m not
having them… not until I am completely cured at
least. But, I have this doubt. Can you get pregnant if
you’re not completely cured?” I-3
“Nobody told me, not even the gynecologist. I didn’t
ask her; maybe she didn’t realize. But, she could have
told me: ‘Look, you can’t pass it on to the fetus, or
there’s a risk of it developing or not, or for it to stay
stable. However, if it develops, you may have to get a
test that can lead to miscarriage or not.’ Nobody told
me that.” I-21
Finally, participants had doubts about how the virus
could affect their partners, if they needed medical fol-
low-up or if they needed to get tested for HPV infec-
tion.
“We are a couple. I mean, I might be hurting him.
I got the impression that I had to think that this
was a private matter and that it wouldn’t affect
anybody else. I think otherwise.” I-1
“There should be a way for men to have it checked.
Make them have a study or test just to see if they are
carriers. That would be really important.” I-9
CIN treatment and follow-up
Our participants showed confusion about the meaning
of the lab results carried out during the gynecological
follow-up and had difficulty understanding the technical
language used by health care professionals.
“The word ASCUS [atypical squamous cells of
undetermined significance] comes to mind. It has
shown up several times in my pap test. I hear it in
isolation in the conversation with my gynecologist and
I think, what’s ASCUS? What’s the relationship of
ASCUS with all this? It’s a long speech I’m given with
a thousand words I don’t understand.… I don’t even
know where to begin to ask questions.” I-18
“The doubt that I had was the number that [the
gynecologist] told me… 16 or 18… I can’t remember
the number she said exactly now. I know that it was
important because I read it. I came home, and read it
one more time. I had no idea what it meant. The
whole thing of the number of the virus left me with
many doubts.” I-13
They did not understand the decisions made by gynecol-
ogists during treatment and follow-up either. For in-
stance, the reasons were unclear for delaying conization
once lesions were detected or for not being given any
treatment.
“I was mentally prepared for the gynecologist telling
me that I had to undergo the conization And then,
it was like why are you not doing it? How come I
only need the vaccine? Don’t you want to treat me?
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Do you want this to get worse? My fear was ‘is this
going to get worse’? CIN 2 means that it may be
cervical cancer?” I-2
They were also doubtful about the usefulness of recom-
mendations such as vaccination, condom use and smok-
ing cessation.
“People say that even with condom use… with just the
minimal touch… it can happen. The condom is not
really that effective because it doesn’t cover the whole
area. I don’t know...” I-19
“And I was told after the diagnosis that it was
beneficial for me to get vaccinated. I didn’t understand
why. If I had already had sexual relationships, why
would I need the vaccine? I was told to get the vaccine
anyway.” I-17
“I knew that tobacco had a link to bladder cancer
and this type of cancer, but I didn’t relate one
thing to the other [cervical cancer and tobacco]. I
didn’t think I had to take any special measures
regarding tobacco.” I-14
Additionally, they considered if there were factors
that determine whether a person is prone to develop-
ing cervical cancer, such as the influence of mood or
genetics.
“There might be people who are more predisposed
to get this. I don’t know if it depends on whether
your defenses are low.” I-21
“The conization coincided with a time when I was
feeling low because my father had died. So, I asked the
gynecologist at one of the consultations if it could have
an effect on all this. The two times I was feeling
emotionally down was when the test came out
positive.” I-10
“Plus, in my family, there is a genetic predisposition [to
cancer], and you know that, sooner or later, it’s going
to be your turn.” I-16
The information they received did not allow them to
differentiate between having an HPV infection and
having CIN. They considered that if they had been
treated for CIN by surgical intervention, the virus
would disappear and they would be “cured” without
the possibility of recurrence.
“Now that I am sort of discharged from the
consultations, I don’t know whether I can infect
other people. In theory, I had all my cells removed
[conization done]. Supposedly, I don’t have anything
anymore, do I?” I-6
“I underwent surgery, and it was a success. I came to
have regular pap smears and everything was OK. I
didn’t know that it could happen again. I had this 10-
11 years ago, and now it’s here again. Why?” I-20
Discussion
Our findings coincide with the international literature in
that women with CIN showed a lack of knowledge about
their condition [3, 5, 7, 8] and that the communication
between health care providers and patients was limited
[7, 9, 11]. Women found it difficult to resolve doubts [7],
which generated feelings of fear and angst [11] and long
periods of great concern between consultations [6]. We
concur that an abnormal pap smear result is unsettling
in part due to a previous lack of information regarding
its purpose [6, 9]. Receiving this result over the phone
produced negative feelings because participants did not
have the possibility to ask questions [13, 29], causing
them to resort to looking for information on the Inter-
net, a source that did not solve their concerns and, for
some, generated more fear [7, 11, 30, 31].
Our study is also a pioneer in identifying different
moments in the health care process, from the diagno-
sis of CIN in primary care to medical follow-up and
treatment in specialized care, in which women experi-
ence health care informational challenges. Another
novel fact is that women in our study emphasized
that the information provided by their primary care
providers at the time of the diagnosis was scarce or
null, and that family physicians/midwives limited
themselves to referring participants to the gynecology
service. Such a way to proceed led to concern and
fear during the waiting period (from days to weeks)
due to the lack of accurate, accessible information
about their situation. Participants expressed the need
for reaching out to a health care professional to ac-
cess information at any point and considered primary
care providers as the best option.
Our participants shared the same doubts about key
information regarding HPV infection and CIN as par-
ticipants of international studies. Most participants
were aware that HPV infection was acquired through
sexual intercourse, although there were exceptions.
Some of them thought that the body could produce
the virus or, as Marlow et al. [32] showed in their
study, some of our participants wondered if the infec-
tion could be acquired in other ways (e.g., sharing ob-
jects or being vaccinated against HPV). As previously
described, at the time of diagnosis, participants did
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not know that the virus has a long latency period
[32]. The lack of information has had psychological
and social impacts on their lives because it raised
questions about their partners’ fidelity [7, 11].
Similar to other studies, our participants did not
know exactly what it meant to have CIN [30], if it
produces symptoms [32, 33] and how it might pro-
gress to cancer [9, 11, 13, 30]. They especially won-
dered if there were factors that could stimulate the
development of cervical cancer, such as genetic fac-
tors or psychological disposition. As described by
other authors, our participants considered whether
the infection could affect areas other than the cervix
[34, 35] and could affect their fertility [9, 30, 36], as
well as what effects it could have during pregnancy
[7, 30] and for their partners’ health [30]. Our study
also confirms previous findings that women have dif-
ficulty understanding the language used by health
care providers [30], as well as the meaning of test re-
sults [6, 9], the decisions that providers make and the
recommendations they offer during treatment and fol-
low-up [3, 5, 34, 37].
Finally, our study reveals that a consequence of the
lack of information about HPV transmission through
distinct sexual practices (e.g., oral sex) was that partici-
pants were living with uncertainty, which interfered with
their sexuality, as they did not know adequate preventive
practices for themselves and their partners. Such find-
ings show that in our interviews sexuality was discussed
in a comprehensive way but did not occur in consulta-
tions with health care professionals; couples’ sexual
practices in the context of prevention were not ad-
dressed. In addition, participants’ lack of understanding
made it impossible for them to differentiate between
HPV infection and CIN. Some of them did not under-
stand why they were not subjected to conization to treat
CIN. They considered that such a treatment would elim-
inate the virus and they would be cured. Based on this
belief, it was difficult for them to understand the gyne-
cologists’ decision to recommend “only” medical follow-
up for their precancerous lesions and made them feel
they were receiving substandard health care.
Strengths and limitations
We believe that two factors greatly contributed to the
success of this study. First, the interviewer (CFV) did
not belong to the gynecological service where the
study was conducted, which allowed participants to
speak freely about their perceptions. Second, partici-
pants were informed that the study aim was to im-
prove health care for women with CIN, which invited
them to reflect and offer critique to the health care
system in a positive way.
There were challenges for this qualitative study as well.
A few participants had no familiarity with in-depth in-
terviews and wanted to provide short, precise answers or
were pressured for time (two interviews lasted 11 and
13min); however, the majority of them took the time to
provide detailed accounts of their experiences. In
addition, this study had a heterogeneous sample regard-
ing age and education because of its exploratory pur-
pose. Future studies should further investigate the
specific needs of different groups of users of the national
health care system, such as young women or immi-
grants, and evaluate the best way to offer information to
each group.
Conclusions
This study shows that women who have a CIN diagnos-
tic experience undergo important health care informa-
tional challenges when accessing primary and specialized
care, which have several implications for their wellbeing.
Participants described informational needs for HPV
transmission, symptoms, treatment and follow-up of
their condition. The information that women receive is
limited, which makes it difficult for them to understand
and participate in decision making regarding prevention
and treatment.
We propose that health care providers should take
into account the different moments of the process
when providing information to patients, as needs dif-
fer from the time of cervical screening in primary
care to CIN follow-up and treatment in specialized
care. Within the context of a publicly funded national
health care system, primary care providers (family
physicians and midwives) have been identified by our
participants as preferred professionals to provide in-
formation, given their accessibility and for their on-
going relationship with them. In specialized health
care, sparse appointments make the information
process fragmented, and health care providers’ tech-
nical language are barriers to overcome.
To facilitate an effective exchange of information with
patients, we believe that health care managers in primary
and specialized care levels should create opportunities to
meet users’ informational needs and take into account
the informational needs manifested by women in our
study to guide future interventions. Health care users
could also greatly benefit from access to accurate infor-
mation in services and online. This study proposes either
the identification of reliable sources of information
already available or the development of educational ma-
terials (digital and printed) to be shared among all levels
of health care to support health education in clinical set-
tings and timely access to accurate information between
appointments.
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